[go: up one dir, main page]

GB9921064D0 - Drug combination - Google Patents

Drug combination

Info

Publication number
GB9921064D0
GB9921064D0 GBGB9921064.3A GB9921064A GB9921064D0 GB 9921064 D0 GB9921064 D0 GB 9921064D0 GB 9921064 A GB9921064 A GB 9921064A GB 9921064 D0 GB9921064 D0 GB 9921064D0
Authority
GB
United Kingdom
Prior art keywords
drug combination
drug
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9921064.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9921064.3A priority Critical patent/GB9921064D0/en
Publication of GB9921064D0 publication Critical patent/GB9921064D0/en
Priority to GBGB0000710.4A priority patent/GB0000710D0/en
Priority to HK02103512.1A priority patent/HK1041817B/en
Priority to TR2001/02228T priority patent/TR200102228T2/en
Priority to HU0104977A priority patent/HU226062B1/en
Priority to SI200030590T priority patent/SI1185274T1/en
Priority to PT00901264T priority patent/PT1185274E/en
Priority to ES00901264T priority patent/ES2232418T3/en
Priority to CNB008034702A priority patent/CN1165310C/en
Priority to JP2000596937A priority patent/JP2002536331A/en
Priority to CZ20012844A priority patent/CZ301296B6/en
Priority to DE60015965T priority patent/DE60015965T2/en
Priority to CA002358632A priority patent/CA2358632C/en
Priority to NZ512982A priority patent/NZ512982A/en
Priority to KR1020067021986A priority patent/KR20060117381A/en
Priority to MXPA01007905A priority patent/MXPA01007905A/en
Priority to AU21218/00A priority patent/AU767304B2/en
Priority to US09/889,414 priority patent/US6982157B1/en
Priority to IDW00200101892A priority patent/ID30485A/en
Priority to BR0007999-5A priority patent/BR0007999A/en
Priority to PCT/GB2000/000278 priority patent/WO2000045817A1/en
Priority to KR1020017009914A priority patent/KR20010101790A/en
Priority to AT00901264T priority patent/ATE282415T1/en
Priority to EEP200100406A priority patent/EE04929B1/en
Priority to EP00901264A priority patent/EP1185274B1/en
Priority to IL14471500A priority patent/IL144715A0/en
Priority to SK1109-2001A priority patent/SK287795B6/en
Priority to PL364780A priority patent/PL198034B1/en
Priority to ARP000100507A priority patent/AR029333A1/en
Priority to MYPI20000416A priority patent/MY130606A/en
Priority to EG20000124A priority patent/EG23858A/en
Priority to TW089102105A priority patent/TWI282738B/en
Priority to IS6009A priority patent/IS2337B/en
Priority to NO20013811A priority patent/NO320745B1/en
Priority to US11/079,530 priority patent/US20060040969A1/en
Priority to JP2007195798A priority patent/JP2007277267A/en
Priority to US12/285,117 priority patent/US20090042911A1/en
Ceased legal-status Critical Current

Links

GBGB9921064.3A 1999-02-06 1999-09-08 Drug combination Ceased GB9921064D0 (en)

Priority Applications (37)

Application Number Priority Date Filing Date Title
GBGB9921064.3A GB9921064D0 (en) 1999-09-08 1999-09-08 Drug combination
GBGB0000710.4A GB0000710D0 (en) 1999-02-06 2000-01-14 Drug combination
PCT/GB2000/000278 WO2000045817A1 (en) 1999-02-06 2000-02-01 Drug combinations comprising (e) -7 - [4 -(4 -fluorophenyl) -6 - isopropyl -2 - [methyl (methylsulfonyl) amino] pyrimidin -5 -yl] (3r,5s) -3,5 - dihydroxyhept -6 - enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
BR0007999-5A BR0007999A (en) 1999-02-06 2000-02-01 Combination of non-interactive drug, pharmaceutical formulation, pharmaceutical packaging, and use of acid (e) - 7 - [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5- il] (3r, 5s) - 3,5-dihydroxyhept-6-enoic, or a pharmaceutically acceptable salt thereof
TR2001/02228T TR200102228T2 (en) 1999-02-06 2000-02-01 (E) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulphonyl) amino] pyrimidin-5-yl] (3R, 5S) -3,5-dihydroxyhept-6- too combinations containing enoic acid and an inhibitor.
HU0104977A HU226062B1 (en) 1999-02-06 2000-02-01 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl-(methylsulfonyl)-amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
SI200030590T SI1185274T1 (en) 1999-02-06 2000-02-01 Drug combinations comprising (e)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(methylsulfonyl)amino)pyrimidin-5-yl)(3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
PT00901264T PT1185274E (en) 1999-02-06 2000-02-01 (E) -7- [4- (4-FLUOROPHENYL) -6-ISOPROPYL-2- [METHYL (METHYLSULPHONYL) AMINO] PYRIMIDIN-5-YL] (3R, 5S) -DIHYDROXY-HEPT -6-ENOIC AND AN INHIBITOR, INDUCTOR OR SUBSTRATE OF ISOENZIMA P450 3A4
ES00901264T ES2232418T3 (en) 1999-02-06 2000-02-01 PHARMACOS COMBINATIONS, WHICH INCLUDE (E) -ACID 7- (4- (4-FLUOROPHENYL) -6-ISOPROPIL-2- (METHYL-SULFONIL) -AMINO) -PIRIMIDIN-5-IL) (3R, 5S) -3,5-DIHYDROXIHEPT-6-ENOICO AND AN INHIBITOR, INDUCTOR OR SUBSTRATE FOR THE ISOENZYME 3A4 OF P450.
CNB008034702A CN1165310C (en) 1999-02-06 2000-02-01 Drug-combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450
JP2000596937A JP2002536331A (en) 1999-02-06 2000-02-01 (E) -7- [4- (4-Fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3R, 5S) -3,5-dihydroxyhept- Combination of 6-enoic acid and a drug comprising an inhibitor, inducer or substrate of P450 isozyme 3A4
CZ20012844A CZ301296B6 (en) 1999-02-06 2000-02-01 Medicament combination containing (E)-7-[4-(fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and inhibitor, inducer or substrate of cytochrome P450 isoenzyme 3A4
DE60015965T DE60015965T2 (en) 1999-02-06 2000-02-01 ACTIVE INCOMPATIBILITIES CONTAINING (E) -7- [4- (4-FLUORO-PHENYL) -6-ISOPROPYL-2- [METHYL (METHYLSULFONYL) AMINO] PYRIMIDIN-5-YL] (3R, 5S) -3,5-DIHYDROXYHEPT-6- ENOIC ACID AND AN INHIBITOR, INDUCER OR SUBSTRATE OF P450 ISOENZYM 3A4
CA002358632A CA2358632C (en) 1999-02-06 2000-02-01 Drug combinations comprising (e)-7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino|pyrimidin-5-yl|(3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
NZ512982A NZ512982A (en) 1999-02-06 2000-02-01 rug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulphonylamino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4
KR1020067021986A KR20060117381A (en) 1999-02-06 2000-02-01 (E) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3R, 5S) -3,5- Drug combinations containing inhibitors, inducers or substrates of dihydroxyhept-6-enoic acid and P450 isoenzyme 3A4
MXPA01007905A MXPA01007905A (en) 1999-02-06 2000-02-01 Drug combinations comprising (e) -7 - [4 -(4 -fluorophenyl) -6 - isopropyl -2 - [methyl (methylsulfonyl) amino] pyrimidin -5 -yl] (3r,5s) -3,5 - dihydroxyhept -6 - enoic acid and an inhibitor,inducer or substrate of p450 isoenzyme 3a4.
AU21218/00A AU767304B2 (en) 1999-02-06 2000-02-01 Drug combinations comprising (E) -7 - (4 -(4 -fluorophenyl) -6 - isopropyl -2 - (methyl (methylsulfonyl) amino) pyrimidin -5 -yl) (3R,5S) -3,5 - dihydroxyhept -6 - enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4
US09/889,414 US6982157B1 (en) 1999-02-06 2000-02-01 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4
HK02103512.1A HK1041817B (en) 1999-02-06 2000-02-01 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r, 5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
IDW00200101892A ID30485A (en) 1999-02-06 2000-02-01 DRUG COMBINATIONS CONTAINING FROM (E) 7 [4 (4 FLUOROPHENYL) 6 ISOPROPHYL 2 [METHYL (METYLSULFONYL) - AMINO] PYRIMIDINE 5 IL] (3R, 5S) 3.5 DIHYDROPHYTT-6- ENOIC ACID AND METHODSULFONYL - AMINO] PYRIMIDINE 5 IL] (3R, 5S) OR MATERIALS FROM ISOENZIM P450 3A4
PL364780A PL198034B1 (en) 1999-02-06 2000-02-01 A non-interacting pharmaceutical combination, including the HMG-CoA reductase inhibitor, which is (E) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5-yl] acid (3R, 5S) -3,5-dihydroxyhept-6-ene or a pharmaceutically acceptable salt thereof and its use
KR1020017009914A KR20010101790A (en) 1999-02-06 2000-02-01 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
AT00901264T ATE282415T1 (en) 1999-02-06 2000-02-01 ACTIVE INGREDIENT COMBINATIONS CONTAINING (E)-7-(4-(4-FLUOROPHENYL)-6-ISOPROPYL-2-
EEP200100406A EE04929B1 (en) 1999-02-06 2000-02-01 A combination of non-interacting drugs, a pharmaceutical composition and a pharmaceutical pack containing (E) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl] (methyl sulfone) l) amino] pyrimidine-5-l] - (3R, 3S) -3,5-dihydroxy hept-6-enoic acid and P450
EP00901264A EP1185274B1 (en) 1999-02-06 2000-02-01 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
IL14471500A IL144715A0 (en) 1999-02-06 2000-02-01 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
SK1109-2001A SK287795B6 (en) 1999-02-06 2000-02-01 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6- isopropyl-2-[methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4
MYPI20000416A MY130606A (en) 1999-02-06 2000-02-04 Drug combinations comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl (methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3a4
ARP000100507A AR029333A1 (en) 1999-02-06 2000-02-04 COMBINATION OF NON-INTERACTIVE DRUGS, PHARMACEUTICAL FORMULATION AND PHARMACEUTICAL PACKAGE INCLUDING SUCH COMBINATION AND THE USE OF AN INHIBITOR OF THE REDUCED HMGCOA IN THE PREPARATION OF A MEDICINAL PRODUCT USED IN COMBINED THERAPY
EG20000124A EG23858A (en) 1999-02-06 2000-02-22 Drug combination
TW089102105A TWI282738B (en) 1999-02-06 2000-05-11 Non-interacting drug combination and pharmacy pack comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid and inhibitor, inducer or substrate of P450 isoenzyme 3A4
IS6009A IS2337B (en) 1999-02-06 2001-07-17 A pharmaceutical composition comprising (E) -7- [4- (4 fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5-yl] (3R, 5S) -3,5-dihydroxyhept-6 -enoic acid and inhibit, monitor or substrate of P450 isomeric enzyme 3A4
NO20013811A NO320745B1 (en) 1999-02-06 2001-08-03 Pharmaceutical drug combinations comprising (E) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl- (methylsulfonyl) amino] pyrimidin-5-yl] - (3R, 5S) -3 , 5-dihydroxy-hept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4 and use thereof
US11/079,530 US20060040969A1 (en) 1999-02-06 2005-03-15 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4
JP2007195798A JP2007277267A (en) 1999-02-06 2007-07-27 Drug combination containing (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and inhibitor, inducer or substrate of p450 isozyme 3a4
US12/285,117 US20090042911A1 (en) 1999-02-06 2008-09-29 Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-YL](3R,5S)-3, 5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 isoenzyme 3A4

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9921064.3A GB9921064D0 (en) 1999-09-08 1999-09-08 Drug combination

Publications (1)

Publication Number Publication Date
GB9921064D0 true GB9921064D0 (en) 1999-11-10

Family

ID=10860457

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9921064.3A Ceased GB9921064D0 (en) 1999-02-06 1999-09-08 Drug combination

Country Status (1)

Country Link
GB (1) GB9921064D0 (en)

Similar Documents

Publication Publication Date Title
EG23858A (en) Drug combination
PL351686A1 (en) Novel pharmaceutical
HUP0203585A3 (en) Pharmaceutical combinations
EG23937A (en) Novel pharmaceutical
GB9930079D0 (en) Medicaments
GB9930071D0 (en) Medicaments
GB9911802D0 (en) Therapeutic combination
GB9911803D0 (en) Therapeutic combination
GB9928607D0 (en) Syringes
GB9911804D0 (en) Therapeutic combination
PL351135A1 (en) Novel pharmaceutical
EG23946A (en) Novel pharmaceutical
IL146341A0 (en) Pharmaceutical complex
GB9924990D0 (en) Medicaments
GB9930083D0 (en) Medicaments
GB9930082D0 (en) Medicaments
GB9929040D0 (en) Medicaments
GB9904935D0 (en) Medicaments
GB9923933D0 (en) Novel pharmaceutical
GB9921764D0 (en) Syringe
GB9921064D0 (en) Drug combination
GB9929039D0 (en) Medicaments
GB9902593D0 (en) Drug combinations
GB9923934D0 (en) Novel pharmaceutical
GB9911499D0 (en) Medicament

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)